ArticleJournal of translational internal medicine2026
Joint association of the frailty index and phenotypic age with all-cause and cause-specific mortality: A prospective cohort study.
Article in Journal of translational internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Little is known about whether frailty index (FI) and phenotypic age (PhenoAge), two independent indicators of biological age, may jointly or interactively predict death risk. Methods: This prospective study was conducted using National Health and Nutrition Examination Survey (NHANES) data of four survey cycles (2003 to 2010) and mortality records until December 31, 2019. FI was calculated for each participant based on his/her responses to 34 questions, and PhenoAge was derived from algorithms using data of nine biomarkers and chronological age. We used Cox proportional hazards (PH) models and competing risk models to estimate the associations of FI, PhenoAge, and their interactions with all-cause mortality and cause-specific mortality. The C-statistic, continuous net reclassification index (NRI), and integrated discrimination improvement (IDI) were used to evaluate model performance. Results: After an updated median follow-up of 11.8 years among 20, 089 adults, a total of 3778 deaths were documented. Each 1 standard deviation (SD) increment in FI and PhenoAgeAccel was associated with 47% (42%-51%) and 41% (38%-45%) higher risk of all-cause mortality, respectively. However, their multiplicative interaction on death risk was not found ( Conclusions: Individual death risk could be better predicted by a joint inclusion of both FI and PhenoAge, indicating that targeting their components may reduce death risk and prolong health span.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.